Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII
Autore:
Scharrer, I; Ehrlich, HJ;
Indirizzi:
Univ Hosp Frankfurt, Ctr Internal Med, D-60596 Frankfurt, Germany Univ Hosp Frankfurt Frankfurt Germany D-60596 D-60596 Frankfurt, Germany Baxter Hyland Immuno, Vienna, Austria Baxter Hyland Immuno Vienna Austria xter Hyland Immuno, Vienna, Austria
Titolo Testata:
HAEMOPHILIA
fascicolo: 4, volume: 7, anno: 2001,
pagine: 346 - 348
SICI:
1351-8216(200107)7:4<346:LOEFII>2.0.ZU;2-1
Fonte:
ISI
Lingua:
ENG
Soggetto:
HEMOPHILIA-A PATIENTS; MULTITRANSFUSED HEMOPHILIA; RISK FACTOR; MULTICENTER; CONCENTRATE; THERAPY; PRODUCT;
Keywords:
blood coagulation factor inhibitors; clinical trials; factor VIII; haemophilia A; incidence; recombinant proteins;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
17
Recensione:
Indirizzi per estratti:
Indirizzo: Scharrer, I Univ Hosp Frankfurt, Ctr Internal Med, Theodor-Stern-Kai 7, D-60596 Frankfurt, Germany Univ Hosp Frankfurt Theodor-Stern-Kai 7 FrankfurtGermany D-60596
Citazione:
I. Scharrer e H.J. Ehrlich, "Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII", HAEMOPHILIA, 7(4), 2001, pp. 346-348

Abstract

De novo inhibitor development is a rare event in PTPs switched from pdFVIII to rFVIII. Based on previously published data of clinical studies a change in FVIII product is unlikely to provoke inhibitor formation.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/03/20 alle ore 14:13:02